PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
31.77%
Similar yoy growth to GNPX's 29.73%. Walter Schloss would note comparable liquidity profiles, looking for differences in deployment efficiency.
No Data
No Data available this quarter, please select a different quarter.
31.77%
Similar yoy growth to GNPX's 29.73%. Walter Schloss would note comparable liquidity expansions. Examine capital usage strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.02%
Similar yoy growth to GNPX's 35.25%. Walter Schloss notes comparable short-term expansions. Investigate quality of these assets.
13.80%
Below half GNPX's -6.85%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.28%
≥ 1.5x GNPX's 1.72%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
31.41%
Similar yoy to GNPX's 34.33%. Walter Schloss sees parallel expansions. Evaluate the quality of these assets.
2.77%
Less than half of GNPX's -39.96%. David Dodd sees a more disciplined AP approach or lower volume.
1023.68%
Higher Short-Term Debt Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-1.85%
Both GNPX and the company show zero Deferred Revenue (Current) Growth.
No Data
No Data available this quarter, please select a different quarter.
1.86%
Less than half of GNPX's 19.98%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.95%
Higher Total Non-Current Liabilities Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-0.43%
Less than half of GNPX's 19.98%. David Dodd sees far fewer liability expansions relative to competitor.
28.57%
Above 1.5x GNPX's 9.26%. Michael Burry suspects heavy new equity expansion or dilution.
-2.84%
Below half GNPX's -9.83%. Michael Burry suspects major net losses or high dividends vs. competitor.
100.00%
Similar yoy to GNPX's 100.00%. Walter Schloss sees parallel comprehensive income changes.
No Data
No Data available this quarter, please select a different quarter.
34.98%
Similar yoy to GNPX's 34.56%. Walter Schloss sees parallel net worth trends.
31.41%
Similar yoy to GNPX's 34.33%. Walter Schloss sees parallel expansions in total capital.
No Data
No Data available this quarter, please select a different quarter.
-15.85%
Higher Total Debt Growth compared to GNPX's zero value, indicating worse performance.
-32.66%
Similar yoy changes to GNPX's -29.73%. Walter Schloss sees parallel net leverage strategies.